In the United Kingdom and European Union, it is notoriously difficult to register slogans as trade marks. To stand a chance of success, brand owners must prepare their case
Read more
What is CRISPR? Clustered regularly interspaced short palindromic repeats (CRISPRs) are a family of DNA sequences found in bacteria.
Read more Despite “convincing arguments” against the strength of the evidence of use submitted by Unilever Plc, following the close-cut decision of the IPO on the 11 November 2019, the applicants’
Read more
Partners and patent attorneys Julia Gwilt and Bobby Smithson discuss: Features of EPO virtual opposition hearings | Unexpected pros | Discreet communication between attorney, client and witness | Learnings & tips | ‘Reading the room’ | Procedural quirks | Would the outcome have been different if parties attended in person?
Read more
The UK Supreme Court handed down the judgment in a much anticipated biotech decision on 24 June. The Court found that Regeneron’s patents are invalid for lack of sufficient disclosure.
Read more
Practical, legal and moral implications where research involves patent-protected drugs One of the big talking points at present is how we can get back to living our lives in a
Read more
Sourcing funding for innovation is currently at the forefront of many businesses’ agenda in response to the current global pandemic. While it is an uncertain time for many, there are
Read more In this judgment at the High Court, Lord Justice Arnold stepped down from the Court of Appeal to the High Court to hear the case. His findings on infringement may
Read more Part one – green energy The National Grid confirmed recently that the UK has completed more than a full month without power input from the country’s coal-fired power stations. With
Read more
This series of articles explores the effect of COVID-19-related disruption on start-ups’ management and monetisation of intellectual property (IP), giving practical guidance to start-ups to improve and preserve their position
Read more
Lab-based scientists may not be able to access their workspace during lockdown, but there are things that can be done remotely to further an IP programme. In part three of our series, “Progressing innovation outside the lab”, we outline strategic tasks that physics and engineering-focused researchers and scientists can complete to further intellectual property during time away from the lab.
Read more
